| Names | |
|---|---|
| Systematic IUPAC name 2-({3-[(2S)-2-Amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.210.061 |
| |
| |
| Properties | |
| C15H15N3O6 | |
| Molar mass | 333.296 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
UBP-302 is a highly selectivekainate receptorantagonist used in the study of manyneurological processes. It is active atmicromolar concentration within anin vitro preparation and specifically targets the GluK1 (iGluR5) subunit of the receptor. This compound was developed at theUniversity of Bristol.[1]
UBP-310 and UBP-316 (ACET) are related N3-substituted willardiine derivatives.[2]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |